Published in Nutr Metab Cardiovasc Dis on September 19, 2011
Mixed Meal Test in Type 1 Diabetes: Optimization of Artificial Pancreas-Pilot Study | NCT01800734
Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care (2000) 9.10
Pathogenesis of NIDDM. A balanced overview. Diabetes Care (1992) 6.56
Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. Diabetes (1998) 3.55
The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nat Genet (2000) 3.08
Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance. J Clin Invest (1989) 3.03
Chronic infections and the risk of carotid atherosclerosis: prospective results from a large population study. Circulation (2001) 2.82
Moderate alcohol use and health: a consensus document. Nutr Metab Cardiovasc Dis (2013) 2.77
Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med (1989) 2.63
Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation. J Clin Endocrinol Metab (2000) 2.43
Insulin sensitivity and regular alcohol consumption: large, prospective, cross sectional population study (Bruneck study) BMJ (1996) 2.42
EGF stimulates lamellipod extension in metastatic mammary adenocarcinoma cells by an actin-dependent mechanism. Clin Exp Metastasis (1996) 2.16
Postprandial blood glucose as a risk factor for cardiovascular disease in Type II diabetes: the epidemiological evidence. Diabetologia (2001) 2.12
Cardiovascular disease and its risk factors in IDDM in Europe. EURODIAB IDDM Complications Study Group. Diabetes Care (1996) 2.11
Estimates of in vivo insulin action in man: comparison of insulin tolerance tests with euglycemic and hyperglycemic glucose clamp studies. J Clin Endocrinol Metab (1989) 2.07
Diabetes impairs progenitor cell mobilisation after hindlimb ischaemia-reperfusion injury in rats. Diabetologia (2006) 2.03
Diabetic retinopathy is associated with an increased incidence of cardiovascular events in Type 2 diabetic patients. Diabet Med (2008) 1.91
The Metabolic Syndrome is an independent predictor of cardiovascular disease in Type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study. Diabet Med (2004) 1.89
Cause-specific mortality in type 2 diabetes. The Verona Diabetes Study. Diabetes Care (1999) 1.86
Plasma glucose levels throughout the day and HbA(1c) interrelationships in type 2 diabetes: implications for treatment and monitoring of metabolic control. Diabetes Care (2001) 1.84
Endothelial progenitors in pulmonary hypertension: new pathophysiology and therapeutic implications. Eur Respir J (2010) 1.83
Analysis of IMGSAC autism susceptibility loci: evidence for sex limited and parent of origin specific effects. J Med Genet (2005) 1.74
Fasting plasma glucose variability predicts 10-year survival of type 2 diabetic patients: the Verona Diabetes Study. Diabetes Care (2000) 1.65
FOXP2 is not a major susceptibility gene for autism or specific language impairment. Am J Hum Genet (2002) 1.63
Assessment of beta-cell function during the oral glucose tolerance test by a minimal model of insulin secretion. Eur J Clin Invest (2001) 1.59
Relationship of uric acid concentration to cardiovascular risk factors in young men. Role of obesity and central fat distribution. The Verona Young Men Atherosclerosis Risk Factors Study. Int J Obes Relat Metab Disord (1996) 1.58
The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab (1991) 1.57
Polynucleotide:adenosine glycosidase activity of ribosome-inactivating proteins: effect on DNA, RNA and poly(A). Nucleic Acids Res (1997) 1.51
Visceral obesity is characterized by impaired nitric oxide-independent vasodilation. Eur Heart J (2003) 1.51
Leucine and phenylalanine kinetics in compensated liver cirrhosis: effects of insulin. Gastroenterology (1993) 1.50
Response of phenylalanine and leucine kinetics to branched chain-enriched amino acids and insulin in patients with cirrhosis. Gastroenterology (1996) 1.48
Screening of nine candidate genes for autism on chromosome 2q reveals rare nonsynonymous variants in the cAMP-GEFII gene. Mol Psychiatry (2003) 1.47
Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM. Diabetes (1996) 1.46
Is it possible to derive a reliable estimate of human visceral and subcutaneous abdominal adipose tissue from simple anthropometric measurements? Metabolism (1995) 1.44
Spironolactone, but not flutamide, administration prevents bone loss in hyperandrogenic women treated with gonadotropin-releasing hormone agonist. J Clin Endocrinol Metab (1999) 1.43
Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients. Diabetologia (2007) 1.40
Extreme insulin resistance in ataxia telangiectasia: defect in affinity of insulin receptors. N Engl J Med (1978) 1.37
Cigarette smoking and insulin resistance in patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab (1997) 1.34
Transmembrane glucose transport in skeletal muscle of patients with non-insulin-dependent diabetes. J Clin Invest (1993) 1.34
New mutations inactivating transferrin receptor 2 in hemochromatosis type 3. Blood (2001) 1.33
Role of free fatty acids and insulin in determining free fatty acid and lipid oxidation in man. J Clin Invest (1991) 1.31
The acute-phase response after bisphosphonate administration. Calcif Tissue Int (1987) 1.29
Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients. Diabetes (1999) 1.28
Clinical and molecular characterisation of 80 patients with 5p deletion: genotype-phenotype correlation. J Med Genet (2001) 1.26
Effect of insulin on oxidative and nonoxidative pathways of free fatty acid metabolism in human obesity. Am J Physiol (1992) 1.25
Decreased hepatic insulin extraction in subjects with mild glucose intolerance. Metabolism (1983) 1.23
Impaired glucose tolerance, Type II diabetes mellitus and carotid atherosclerosis: prospective results from the Bruneck Study. Diabetologia (2000) 1.23
The Verona diabetes study: a population-based survey on known diabetes mellitus prevalence and 5-year all-cause mortality. Diabetologia (1995) 1.21
Glucose tolerance is negatively associated with circulating progenitor cell levels. Diabetologia (2007) 1.21
Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients. Troglitazone Study Group. Diabetologia (1996) 1.17
Body mass index and the risk of mortality in type II diabetic patients from Verona. Int J Obes Relat Metab Disord (2003) 1.15
Intimal-medial thickness of the carotid artery in nondiabetic and NIDDM patients. Relationship with insulin resistance. Diabetes Care (1997) 1.14
Serum uric acid and related factors in 500 hospitalized subjects. Metabolism (1996) 1.14
ACE inhibitors improve endothelial function in type 1 diabetic patients with normal arterial pressure and microalbuminuria. Diabetes Care (1999) 1.14
Long-term instability of fasting plasma glucose, a novel predictor of cardiovascular mortality in elderly patients with non-insulin-dependent diabetes mellitus: the Verona Diabetes Study. Circulation (1997) 1.12
Insulin sensitivity and glucose effectiveness: minimal model analysis of regular and insulin-modified FSIGT. Am J Physiol (1998) 1.12
Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and retinopathy in type 1 diabetic patients. Diabetologia (2010) 1.12
Diabetes duration and cause-specific mortality in the Verona Diabetes Study. Diabetes Care (2000) 1.11
Capture-recapture method in the epidemiology of type 2 diabetes: a contribution from the Verona Diabetes Study. Diabetes Care (2000) 1.11
Glycemic index in the diet of European outpatients with type 1 diabetes: relations to glycated hemoglobin and serum lipids. Am J Clin Nutr (2001) 1.10
Regulation of insulin receptors in normal and abnormal physiology in humans. Adv Intern Med (1979) 1.10
Gender differences in cardiovascular disease risk factors, treatments and complications in patients with type 2 diabetes: the RIACE Italian multicentre study. J Intern Med (2013) 1.10
Effects of glucosamine infusion on insulin secretion and insulin action in humans. Diabetes (2000) 1.10
Alcohol consumption and atherosclerosis: what is the relation? Prospective results from the Bruneck Study. Stroke (1998) 1.09
Role of tissue-specific blood flow and tissue recruitment in insulin-mediated glucose uptake of human skeletal muscle. Circulation (1998) 1.08
Pancreatic diabetes manifests when beta cell area declines by approximately 65% in humans. Diabetologia (2012) 1.08
Undermodeling affects minimal model indexes: insights from a two-compartment model. Am J Physiol (1999) 1.08
Attending the diabetes center is associated with increased 5-year survival probability of diabetic patients: the Verona Diabetes Study. Diabetes Care (1996) 1.06
Causes of food-induced anaphylaxis in Italian adults: a multi-centre study. Int Arch Allergy Immunol (2009) 1.06
Characterization of cellular defects of insulin action in type 2 (non-insulin-dependent) diabetes mellitus. J Clin Invest (1993) 1.06
The insulin resistance of acromegaly: evidence for two alterations in the insulin receptor on circulating monocytes. J Clin Endocrinol Metab (1979) 1.05
The insulin resistance in women with hyperandrogenism is partially reversed by antiandrogen treatment: evidence that androgens impair insulin action in women. J Clin Endocrinol Metab (1996) 1.05
Changes in insulin and lipid metabolism in males with asymptomatic hyperuricaemia. J Intern Med (1993) 1.04
An unidentified pancreatic cancer cell product alters some intracellular pathways of glucose metabolism in isolated rat hepatocytes. Pancreas (1997) 1.03
Evidence that multiple risk factors for coronary artery disease exist in persons with abnormal glucose tolerance. Am J Med (1987) 1.03
Elevated levels of interleukin-6 in young adults with type 1 diabetes without clinical evidence of microvascular and macrovascular complications. Diabetes Care (2001) 1.03
Metabolic syndrome: epidemiology and more extensive phenotypic description. Cross-sectional data from the Bruneck Study. Int J Obes Relat Metab Disord (2003) 1.02